French Food Safety Agency (Afssa), Viral Genetics and Biosafety Unit, Fr-22440, Ploufragan, France.
Vaccine. 2010 May 21;28(23):3888-95. doi: 10.1016/j.vaccine.2010.03.040. Epub 2010 Apr 4.
DNA vaccination has been widely studied to develop new, alternative, efficient and safe vaccines for humans and animals. Many efforts have been made to increase the immunising potential of these vaccines and three veterinary vaccines are now available on the market. Much work is also being dedicated to develop effective DNA vaccines for humans. However, this new vaccination technique raises issues concerning biosafety due to the nature of the vector, i.e. a DNA molecule that contains sequences of prokaryotic origin (e.g. genes for antibiotic resistance). This review describes the development of the new generation of DNA vectors that are partially or completely devoid of elements of prokaryotic origin and outlines the results of studies on the fate of plasmids after their injection in vivo.
DNA 疫苗已被广泛研究,以开发用于人类和动物的新型、替代、高效和安全疫苗。许多努力都旨在提高这些疫苗的免疫原性,目前已有三种兽用疫苗上市。人们还在努力开发针对人类的有效 DNA 疫苗。然而,由于载体的性质(即含有原核起源序列的 DNA 分子,例如抗生素抗性基因),这种新型疫苗接种技术引发了生物安全性问题。本综述描述了新一代 DNA 载体的开发,这些载体部分或完全不含原核起源的元件,并概述了在体内注射后质粒命运的研究结果。